Johnson & Johnson said Monday it would pay $480 million for medical device maker Micrus Endovascular, adding a range of treatments for stroke and brain aneurysms.
The deal is expected to close during the second half of 2010.
Micrus, based in San Jose, Calif., focuses on devices aimed at treating stroke and aneurysms. Revenue reached $91.1 million in the fiscal year ended in March.
Most of Micrus' products to treat and prevent nonembolic strokes are manufactured in Miramar, where the company has an undisclosed number of administrative, manufacturing, research and development employees.
Latest from Today's Medical Developments
- Stryker’s flexible syndesmotic fixation device stabilizes ankle injuries
- Mergers & acquisitions news: MGS, Quantum Surgical bolster medtech portfolios
- Exchangeable-head solid carbide cutting tools
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
